Our data elucidate the oncogenic and drug-resistant role of NAT10 in HCC and highlight the importance of ac4C modification as a novel gene epigenetic regulatory pathway in tumor development, providing new insights into further mechanisms of tumorigenesis and progression. The gene discussed is NAT10; the disease is hepatocellular carcinoma.